The role of the host defence response in the progression and outcome of ARDS: pathophysiological correlations and response to glucocorticoid treatment

The host defence response (HDR) to insults is similar regardless of the tissue involved and consists of an interactive network of simultaneously activated pathways that act in synergy to increase the host's chance of survival. Among this cascade of integrated pathways, three aspects of the HDR, inflammation, coagulation and tissue repair, are analysed separately to explain the histological and physiological changes occurring at the tissue level in unresolving acute respiratory distress syndrome (ARDS). Cellular responses in HDR are regulated by a complex interaction among cytokines, and cytokines have concentration-dependent biological effects. The degree of initial HDR may determine the progression of ARDS. On Day 1 of mechanical ventilation and over time, nonsurvivors of ARDS have significantly higher plasma and bronchoalveolar lavage inflammatory cytokine levels than survivors. In the absence of inhibitory signals, the continued production of HDR mediators prevents effective restoration of lung anatomy and function by sustaining inflammation with tissue injury, intra- and extravascular coagulation and proliferation of mesenchymal cells (fibroproliferation) with deposition of extracellular matrix resulting in fibrosis. Glucocorticoids inhibit the HDR cascade at virtually all levels; their gradual and generalized suppressive influence protects the host from overshooting. In patients with exaggerated HDR, however, cytokine elevation may cause a concentration-dependent resistance to glucocorticoids by reducing glucocorticoid receptor binding affinity. Recent clinical and experimental studies have shown that effective containment of the HDR in unresolving ARDS may be achieved only if glucocorticoid administration is prolonged. A double-blind randomized study is in progress to evaluate the role of prolonged glucocorticoid treatment in unresolving ARDS.

This article has been cited by other articles:

				T. Xu, J. Qiao, L. Zhao, G. He, K. Li, J. Wang, Y. Tian, and H. Wang Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice Eur. Respir. J., April 1, 2009; 33(4): 852 - 860. [Abstract] [Full Text] [PDF]

				G. U. Meduri There Is No Illumination in Speculation: Additional Data in Support of Methylprednisolone Treatment in ARDS Chest, September 1, 2007; 132(3): 1097 - 1100. [Full Text] [PDF]

				T. A. Russo, Z. Wang, B. A. Davidson, S. A. Genagon, J. M. Beanan, R. Olson, B. A. Holm, P. R. Knight 3rd, P. R. Chess, and R. H. Notter Surfactant dysfunction and lung injury due to the E. coli virulence factor hemolysin in a rat pneumonia model Am J Physiol Lung Cell Mol Physiol, March 1, 2007; 292(3): L632 - L643. [Abstract] [Full Text] [PDF]

				F. B. Santos, L. K. S. Nagato, N. M. Boechem, E. M. Negri, A. Guimaraes, V. L. Capelozzi, D. S. Faffe, W. A. Zin, and P. R. M. Rocco Time course of lung parenchyma remodeling in pulmonary and extrapulmonary acute lung injury J Appl Physiol, January 1, 2006; 100(1): 98 - 106. [Abstract] [Full Text] [PDF]

				Y. Abadie, F. Bregeon, L. Papazian, F. Lange, B. Chailley-Heu, P. Thomas, P. Duvaldestin, S. Adnot, B. Maitre, and C. Delclaux Decreased VEGF concentration in lung tissue and vascular injury during ARDS Eur. Respir. J., January 1, 2005; 25(1): 139 - 146. [Abstract] [Full Text] [PDF]

				P. Prodhan and N. Noviski Pediatric Acute Hypoxemic Respiratory Failure: Management of Oxygenation J Intensive Care Med, May 1, 2004; 19(3): 140 - 153. [Abstract] [PDF]

				G.U. Meduri, P. Carratu, and A.X. Freire Evidence of biological efficacy for prolonged glucocorticoid treatment in patients with unresolving ARDS Eur. Respir. J., August 1, 2003; 22(42_suppl): 57s - 64s. [Abstract] [Full Text] [PDF]

				G. U. Meduri, S. Kanangat, M. Bronze, D. R. Patterson, C. U. Meduri, C. Pak, E. A. Tolley, and D. R. Schaberg Effects of Methylprednisolone on Intracellular Bacterial Growth Clin. Vaccine Immunol., November 1, 2001; 8(6): 1156 - 1163. [Abstract] [Full Text] [PDF]

				P. R. M. ROCCO, E. M. NEGRI, P. M. KURTZ, F. P. VASCONCELLOS, G. H. SILVA, V. L. CAPELOZZI, P. V. ROMERO, and W. A. ZIN Lung Tissue Mechanics and Extracellular Matrix Remodeling in Acute Lung Injury Am. J. Respir. Crit. Care Med., September 15, 2001; 164(6): 1067 - 1071. [Abstract] [Full Text] [PDF]

				B. Maitre, S. Boussat, D. Jean, M. Gouge, L. Brochard, B. Housset, S. Adnot, and C. Delclaux Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury Eur. Respir. J., July 1, 2001; 18(1): 100 - 106. [Abstract] [Full Text] [PDF]

				L. Salez, V. Balloy, N. van Rooijen, M. Lebastard, L. Touqui, F. X. McCormack, and M. Chignard Surfactant Protein A Suppresses Lipopolysaccharide-Induced IL-10 Production by Murine Macrophages J. Immunol., May 15, 2001; 166(10): 6376 - 6382. [Abstract] [Full Text] [PDF]

				M. Chignard and V. Balloy Neutrophil recruitment and increased permeability during acute lung injury induced by lipopolysaccharide Am J Physiol Lung Cell Mol Physiol, December 1, 2000; 279(6): L1083 - L1090. [Abstract] [Full Text] [PDF]

				R. P. MARSHALL, G. BELLINGAN, S. WEBB, A. PUDDICOMBE, N. GOLDSACK, R. J. MCANULTY, and G. J. LAURENT Fibroproliferation Occurs Early in the Acute Respiratory Distress Syndrome and Impacts on Outcome Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1783 - 1788. [Abstract] [Full Text]

				J. J. Boelens, S. A. J. Zaat, J. L. Murk, J. J. Weening, T. van der Poll, and J. Dankert Enhanced Susceptibility to Subcutaneous Abscess Formation and Persistent Infection around Catheters Is Associated with Sustained Interleukin-1beta Levels Infect. Immun., March 1, 2000; 68(3): 1692 - 1695. [Abstract] [Full Text] [PDF]

				P. Cooper, B. Mueck, S. Yousefi, S. Potter, and G. Jarai cDNA-RDA of genes expressed in fetal and adult lungs identifies factors important in development and function Am J Physiol Lung Cell Mol Physiol, February 1, 2000; 278(2): L284 - L293. [Abstract] [Full Text] [PDF]

				M. A. JANTZ and S. A. SAHN Corticosteroids in Acute Respiratory Failure Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1079 - 1100. [Full Text]

				G. UMBERTO MEDURI, S. KANANGAT, J. STEFAN, E. TOLLEY, and D. SCHABERG Cytokines IL-1beta , IL-6, and TNF-alpha Enhance In Vitro Growth of Bacteria Am. J. Respir. Crit. Care Med., September 1, 1999; 160(3): 961 - 967. [Abstract] [Full Text]

				G. U. Meduri Levels of Evidence for the Pharmacologic Effectiveness of Prolonged Methylprednisolone Treatment in Unresolving ARDS Chest, July 1, 1999; 116(2007): 116S - 118S. [Full Text]

				S. Kanangat, G. U. Meduri, E. A. Tolley, D. R. Patterson, C. U. Meduri, C. Pak, J. P. Griffin, M. S. Bronze, and D. R. Schaberg Effects of Cytokines and Endotoxin on the Intracellular Growth of Bacteria Infect. Immun., June 1, 1999; 67(6): 2834 - 2840. [Abstract] [Full Text] [PDF]

				G. UMBERTO MEDURI, E. A. TOLLEY, A. CHINN, F. STENTZ, and A. POSTLETHWAITE Procollagen Types I and III Aminoterminal Propeptide Levels during Acute Respiratory Distress Syndrome and in Response to Methylprednisolone Treatment Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1432 - 1441. [Abstract] [Full Text] [PDF]

				G. U. MEDURI, R. C. REDDY, T. STANLEY, and F. EL-ZEKY Pneumonia in Acute Respiratory Distress Syndrome . A Prospective Evaluation of Bilateral Bronchoscopic Sampling Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 870 - 875. [Abstract] [Full Text] [PDF]

				G. U. Meduri, A. S. Headley, E. Golden, S. J. Carson, R. A. Umberger, T. Kelso, and E. A. Tolley Effect of Prolonged Methylprednisolone Therapy in Unresolving Acute Respiratory Distress Syndrome: A Randomized Controlled Trial JAMA, July 8, 1998; 280(2): 159 - 165. [Abstract] [Full Text] [PDF]